OpenAI’s latest image update to ChatGPT isn’t just a boon for Studio Ghibli fans. It’s also a gift to businesses of all sizes ...

As STAT’s Katie Palmer reports in a new story, the lack of standards for collection of this information will make it more ...

Isomorphic Labs, which broke off from Google's DeepMind in 2021, raised $600 million from investors in a new funding round ...

Isomorphic Labs CEO Demis Hassabis discusses $600M funding round, plans for a US office, and expanding into ...

Before today’s main column about the AI attention war between OpenAI and Google, there’s OpenAI news from my colleague Natasha: ChatGPT has hit 20 million paid subscribers, according to a spokesperson ...

The companies Isomorphic Labs, DBV Technologies, and Genfit bagged the biggest biotech funding rounds overall in March 2025.

UK-based AI-first development company Isomorphic Labs revealed that it has raised $600 Million in its first external funding round. The financing round is led by Thrive Capital, with participation ...

Demis Hassabis, cofounder of DeepMind and 2024 Nobel Laureate, talks to Fortune about his AI drug discovery startup, ...

Google’s CEO Sundar Pichai has announced that the recently introduced Canvas tool for the Gemini app is now available for ...

Though Isomorphic is burning through millions in R&D costs now, investors have high hopes for the potential of AI drug ...

Isomorphic Labs was founded to apply artificial intelligence to drug discovery. The company is led by AI researcher Sir Demis Hassabis.

Wall Street stocks posted their worst quarter in almost three years on fears that Donald Trump’s tariffs will usher in a period of stagflation in the world’s biggest economy. The S&P 500 dropped 4.6 ...